$512.16
3.33%
NYSE, Sep 25, 04:00 pm EDT. Closed.

Chemed Corporation Target price 2026 - Analyst rating & recommendation

Chemed Corporation Classifications & Recommendation

Buy
50%
Hold
50%

Chemed Corporation Price Target

Target Price $559.98
Price $512.16
Potential
Number of Estimates 5
5 Analysts have issued a price target Chemed Corporation 2027 . The average Chemed Corporation target price is $559.98. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 8 analysts: 4 Analysts recommend Chemed Corporation to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Chemed Corporation stock has an average upside potential 2027 of . Most analysts recommend the Chemed Corporation stock at Buy or hold.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 2.53 2.75
4.06% 8.62%
EBITDA Margin 16.69% 18.98%
13.73% 13.74%
Net Margin 10.48% 12.21%
15.60% 16.46%

5 Analysts have issued a sales forecast Chemed Corporation 2026 . The average Chemed Corporation sales estimate is

$2.7b
unlock
. This is
5.90% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$2.9b 10.21%
unlock
, the lowest is
$2.7b 2.58%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $2.5b 4.06%
2026
$2.7b 8.62%
unlock
2027
$2.9b 5.93%
unlock
2028
$3.1b 5.87%
unlock

5 Analysts have issued an Chemed Corporation EBITDA forecast 2026. The average Chemed Corporation EBITDA estimate is

$522m
unlock
. This is
18.65% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$546m 24.11%
unlock
, the lowest is
$503m 14.38%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $422m 10.23%
2026
$522m 23.53%
unlock
2027
$551m 5.71%
unlock
2028
$578m 4.84%
unlock

EBITDA Margin

2025 16.69% 13.73%
2026
18.98% 13.74%
unlock
2027
18.94% 0.21%
unlock
2028
18.75% 1.00%
unlock

5 Chemed Corporation Analysts have issued a net profit forecast 2026. The average Chemed Corporation net profit estimate is

$336m
unlock
. This is
22.05% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$350m 27.37%
unlock
, the lowest is
$324m 17.81%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $265m 12.17%
2026
$336m 26.54%
unlock
2027
$362m 7.84%
unlock
2028
$386m 6.56%
unlock

Net Margin

2025 10.48% 15.60%
2026
12.21% 16.46%
unlock
2027
12.43% 1.80%
unlock
2028
12.51% 0.64%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 18.34 25.78
7.79% 40.57%
P/E 19.87
EV/Sales 2.48

5 Analysts have issued a Chemed Corporation forecast for earnings per share. The average Chemed Corporation EPS is

$25.78
unlock
. This is
23.76% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$26.90 29.14%
unlock
, the lowest is
$24.88 19.44%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $18.34 7.79%
2026
$25.78 40.57%
unlock
2027
$27.80 7.84%
unlock
2028
$29.62 6.55%
unlock

P/E ratio

Current 24.59 7.32%
2026
19.87 19.19%
unlock
2027
18.42 7.30%
unlock
2028
17.29 6.13%
unlock

Based on analysts' sales estimates for 2026, the Chemed Corporation stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.63 4.37%
2026
2.48 5.52%
unlock
2027
2.35 5.60%
unlock
2028
2.22 5.55%
unlock

P/S ratio

Current 2.58 1.68%
2026
2.44 5.57%
unlock
2027
2.30 5.60%
unlock
2028
2.17 5.55%
unlock

Current Chemed Corporation Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
UBS
Locked
➜
Locked
Locked Sep 25 2026
Oppenheimer
Locked
➜
Locked
Locked Jul 31 2026
RBC Capital
Locked
➜
Locked
Locked Jul 30 2026
B of A Securities
Locked
➜
Locked
Locked Jul 09 2026
RBC Capital
Locked
➜
Locked
Locked Apr 27 2026
RBC Capital
Locked
➜
Locked
Locked Feb 27 2026
Oppenheimer
Locked
➜
Locked
Locked Feb 27 2026
Analyst Rating Date
Locked
UBS:
Locked
➜
Locked
Sep 25 2026
Locked
Oppenheimer:
Locked
➜
Locked
Jul 31 2026
Locked
RBC Capital:
Locked
➜
Locked
Jul 30 2026
Locked
B of A Securities:
Locked
➜
Locked
Jul 09 2026
Locked
RBC Capital:
Locked
➜
Locked
Apr 27 2026
Locked
RBC Capital:
Locked
➜
Locked
Feb 27 2026
Locked
Oppenheimer:
Locked
➜
Locked
Feb 27 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today